Content area
Abstract
Key Clinical Points
Community-Acquired Pneumonia
The diagnosis of community-acquired pneumonia is made on the basis of compatible symptoms and signs, with evidence of a new infiltrate on an imaging study.
Most outpatients with mild community-acquired pneumonia can be treated empirically without diagnostic testing for bacteria. However, testing for SARS-CoV-2 and influenza should be considered.
A comprehensive approach to microbiologic testing for hospitalized patients is recommended for determining the appropriate pathogen-directed therapy.
The choice of antimicrobial therapy for community-acquired pneumonia varies according to severity, coexisting conditions, and the likelihood of antimicrobial-resistant organisms.
Details
Title
Community-Acquired Pneumonia
Author
File, Thomas M, Jr; Ramirez, Julio A 1
1 From the Division of Infectious Disease, Summa Health, Akron, and the Section of Infectious Disease, Northeast Ohio Medical University, Rootstown — both in Ohio (T.M.F.); and Norton Infectious Diseases Institute, Norton Healthcare, and the Division of Infectious Diseases, University of Louisville — both in Louisville, KY (J.A.R.).
1 From the Division of Infectious Disease, Summa Health, Akron, and the Section of Infectious Disease, Northeast Ohio Medical University, Rootstown — both in Ohio (T.M.F.); and Norton Infectious Diseases Institute, Norton Healthcare, and the Division of Infectious Diseases, University of Louisville — both in Louisville, KY (J.A.R.).
Pages
632-641
Section
Clinical Practice
Publication year
2023
Publication date
Aug 17, 2023
Website
ISSN
00284793
e-ISSN
15334406
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2851960900
Copyright
Copyright © 2023 Massachusetts Medical Society. All rights reserved.